Tuesday, April 17, 2007

Midday update - Would I lie to you ?

Well this morning it has been relatively quiet on the Ashcoff war front. Well ...by quiet I mean we haven't seen the normal fury of numerous reiterations by Ashcoff.

We've only had one little teeny weeny new report out in premarket that cited Aschoff's sell recommendation with this very ambiguous title that could be seen as an outright lie.

" Dendreon Cooperation Denied By The FDA"


What you talking about Ashcoff ...er Willace ?


Well last time I checked the FDA does not send out press releases concerning thier approval desicions about life extending cancer drugs to third party online publishing companies based in foreign countries. Especially not citing the opinion of a man who impersonated a doctor.

Today's article , and the other articles citing Ashoff yesterday , came from London based M2 media which releases these 'Dendreon Alerts' without ever mentioning who is publishing them.

I'm not saying Aschoff himself had anything to do with it , however it does reiterate his sell position on DNDN with a heading that could be viewed as an outright lie.


Even though the title of today's M2 'alert' was very misleading it was picked up by several brokerage houses as a DNDN stock alert.

People tend to trust new releases they see being issued by their brokerage houses that they choose on put thier money in.

Now if I was an average investor who wasn't up to par on the whole Dendreon case ; seeing this headline after logging in to my Scottrade account would make me drop my morning cup of coffee and run to hit the sell button!

The monumental FDA decision is to be made by May 15 , and I'm pretty sure the news of approval won't be coming from a third party publisher who doesn't even care to bother to release their identity.


Oh and I've received a couple of comments asking about the authenticity of the Wall Street Journal Article I posted yesterday

Here's an article on the WSJ page

http://pqasb.pqarchiver.com/wsj/access/147315131.html?dids=147315131:147315131&FMT=ABS&FMTS=ABS:FT&date=Aug+8%2C+2002&author=By+Geeta+Anand+and+Randall+Smith&pub=Wall+Street+Journal&edition=Eastern+edition&startpage=A.1&type=91_1996&desc=Trial+Heat%3A++Biotech+Analysts+Strive+to+Peek++Inside+Clinical+Tests+of+Drugs++---++One+Impersonated+a+Patient%2C++One+a+Doctor

If you want to read the full article posted yesterday you can find it here on Pulitzer.org

http://www.pulitzer.org/year/2003/explanatory-reporting/works/wsj10.html




Signing off ,

Pineal Gland